Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market - Abivax (OTC:AAVXF)

PARIS, FRANCE / ACCESSWIRE / October 24, 2023 / Abivax SA (PARIS:FR) (" Abivax " or the " Company "), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's

Related Keywords

New York ,United States ,Paris ,France General ,France ,Boston ,Massachusetts ,Republic Of France ,French , ,Leerink Partners ,Garnier Co ,Morgan Stanley Co ,Syndicate Department ,Exchange Commission ,Prospectus Department ,Morgan Stanley ,Nasdaq Global Market ,American Depositary Shares ,Private Placement ,European Private ,Global Offering ,Euronext Paris ,Lifesci Capital ,European Private Placement ,Member State ,European Economic Area ,Relevant State ,Prospectus Regulation ,French Monetary ,Financial Code ,